In both the American and Mediterranean deficiencies, heterozygous females present enzyme levels that are intermediate between but also overlap with those of normal and of mutant hemizygous males (Beutler, Yeh, and Fairbanks, I962; Adinolfi, Davidson, Latte, Meera Khan, Piomelli, Ratazzi, and Siniscalco, I963; Davidson et al., I964) . Moreover, Sardinian females clinically affected with haemolytic favism are observed with a frequency that is higher than the number of homozygotes and lower than the number of heterozygotes expected on the basis of the local gene frequencies (E. Sartori, unpublished data).
These discrepancies could be explained by the Lyon hypothesis (I962) which postulates that one of the two X chromosomes of normal females is genetically inactive and that either of the two X chromosomes may be inactivated in early embryonic life at random in different cells of the same individual.
According to Beutler et al. (i962) an implication of the hypothesis is the existence, in the G6PD deficient heterozygotes, of two distinct cell populations, one normal and one deficient. This assumption has been submitted to experimental tests by many authors. Among those who confirm the hypothesis, some have not considered sufficiently the possibility that the erythrocytes can behave as if they were composed of two distinct populations also in hemizygous males, provided that their behaviour is referred to an appropriate single measurement. Thus it was well known that in primaquine-sensitivity the haemolysis was clinically and haematologically self-limited and that the limit was related to cell age as well as to the dose of the drug (Dern, Beutler, and Alving, I954; Kellermeyer, Tarlov, Schrier, Carson, and Alving, I96I) . The haemolysis is self-limited also in haemolytic favism (Sartori and Panizon, I957) . Furthermore Frischer, Bowman, and Carson (I964) Evidence against the hypothesis derives in the first place from failure to detect in the blood of heterozygotes a portion of DF32 P-labelled erythrocytes behaving in vivo as normal ones (Brewer, Tarlov, and Powell, i962) , and secondly for failure to separate from the blood of double heterozygotes Xg (a +) and Xg (a -) erythrocytes with different G6PD activities, which could easily be separated from artificial mixtures of hemizygous bloods (Gorman, Dire, Treacy, and Cahan, i963) .
As to this negative evidence, we think that the longterm survival behaviour in vivo of a double population of erythrocytes can hardly be predicted with sufficient precision. Furthermore, the Xga locus may belong to a non-inactivated region of the X chromosome. Such an hypothesis has been formulated by Russell (1963) to explain some variegated type position effects in the mouse, by limitation in spread and in region of origin of the inactivation of the mammalian X chromosome.
In conclusion, the existence of a true erythrocyte mosaic in females heterozygous for G6PD-deficiency is still open to some doubt, and further investigations are desirable.
Given the appropriate variable, two normal distributions of it found in heterozygotes would prove the mosaic, while a single distribution would exclude it. We searched accordingly for a variable that would give normal distributions for both normal and mutant hemizygous erythrocytes and first tried with primaquine. Panizon and Zacchello (I965) in fact observed that erythrocytes of enzyme-deficient males, labelled with 5GCr and then transfused, underwent an almost complete destruction within one day when first incubated with oi0o mg./ml. primaquine, while only about half the deficient cells were destroyed if the drug was lowered to o o2 mg./ml. Primaquine, however, proved to be unsuitable, since at higher doses it modifies the blood physically, and it was, therefore, impossible to obtain a distribution for normal cells. We finally succeeded in our purpose by first damaging the erythrocytes in vitro with increasing concentrations of menadione sodium bisulphite, the hydrosoluble vitamin K3, and then destroying the damaged ones in vivo by means of transfusing the blood into compatible recipients, after having labelled it with 51Cr. The proportion of destroyed cells was finally inferred from short-term survival determinations.
Material and Methods
Subjects. Blood was drawn from 8 healthy Italian adults, Wassermann negative and without history of malaria. Four were males, two of them normal and two strongly deficient for erythrocyte G6PD-activity. The other four were females heterozygous for the mutant gene. In three, heterozygosity was proven because each had at least one normal and one enzyme-deficient son; in the fourth, heterozygosity was strongly presumptive because her father had suffered from haemolytic favism, but she presented only minor fava-induced disorders and repeatedly showed intermediate values for erythrocyte G6PD activity. Recipients were normal volunteers, compatible for ABO and Rh blood groups.
Glutathione and Enzyme Determinations. Erythrocyte-reduced glutathione (GSH), before and after incubation (for 2 hours at 370 C. with 5 mg./ml. acetylphenylhydrazine and 2 mg./ml. glucose), was determined by the method of Beutler, Duron, and Kelly (i963 From each donor, 7 samples of heparinized blood, fresh or stored for no longer than I2 hours at about 40 C., to which were added i % of a sterile 20% glucose solution, were tried against consecutive dilutions of MSB, ranging therefore, assumed that the radioactive salt entered equally into normal and mutant erythrocytes and was equally eluted from both, and that the decay of radioactivity during the short time considered was caused chiefly by destruction of erythrocytes altered by the exposure to MSB.
As different quantities of the substance added to the same blood led to different amounts of destroyed erythrocytes, it was further assumed that there was a continuous variability in their resistance against MSB damage and that this variability might be reflected by the differences between the radioactivity percentage figures of the 24-hour samples obtained after incubation with subsequent MSB dilutions. Since we found good agreement between the values obtained from the blood of the same donor tested against the same dilutions at different times in different recipients, we also postulated that the individual differences among the recipients would not introduce any serious bias.
Results
The results listed in Table II and summarized in Fig. i were essentially as follows: (i) Both in the normal and in the mutant hemlizygous blood the resistance of the erythrocytes against MSBdamage behaves as a nearly normally distributed function of the logarithm ofthe MSB-concentration.
(2) There is a considerable difference between the ranges of concentration that damage the normal and those that damage the mutant erythrocytes, the latter being definitely lower. 
